Physician- and patient-reported outcomes in patients with moderate plaque psoriasis treated with apremilast during routine dermatology care in Germany

被引：0

作者：

Reich, K. ^{[1
,2
]}

Fritzlar, S.

Korge, B.

Manasterski, M.

Schwichtenberg, U. ^{[3
]}

Morys, S. ^{[4
]}

Lampl, M. ^{[4
]}

Roemmler-Zehrer, J. ^{[4
]}

Gomez, Nunez N. ^{[4
]}

机构：

[1] SCIderm Res Inst, Hamburg, Germany

[2] Dermatologikum Berlin, Berlin, Germany

[3] Derma Nord Hautarztpraxen Dr med Schwichtenberg, Bremen, Germany

[4] Celgene GmbH, Munich, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2019年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P115-A

引用

页码：123 / 124

页数：2

共 50 条

[31] Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient-reported outcomes from a Phase 3 study
Valenzuela, F.
Paul, C.
Mallbris, L.
Tan, H.
Papacharalambous, J.
Valdez, H.
Mamolo, C.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (10) : 1753 - 1759
[32] Clinically meaningful improvements in patient-reported outcomes for patients with moderate to severe psoriasis receiving etanercept
Krueger, G
Woolley, J
Zitnik, R
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A55 - A55
[33] Impact of adalimumab treatment on patient-reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis
Revicki, Dennis A.
Willian, Mary Kaye
Menter, Alan
Gordon, Kenneth B.
Kimball, Alexa B.
Leonardi, Craig L.
Langley, Richard G.
Kimel, Miriam
Okun, Martin
JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (06) : 341 - 350
[34] Development of a patient-reported outcomes instrument for the measurement of treatment satisfaction in plaque psoriasis
Armstrong, April
Sundaram, Murali
Foley, Catherine
Pompilus, Farrah
Stokes, Jonathan
Shields, Alan
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S34 - S34
[35] Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial
Thyssen, Jacob P.
Werfel, Thomas
Barbarot, Sebastien
Hunter, Hamish J. A.
Pierce, Evangeline
Sun, Luna
Cirri, Lisa
Buchanan, Andrew S.
Lu, Na
Wollenberg, Andreas
JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
[36] Impact of sustained robust response on patient-reported outcomes for adalimumab-treated patients with moderate to severe psoriasis: Subanalysis of REVEAL
Strober, Bruce
Sundaram, Murali
Bao, Yanjun
Gu, Yihua
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB194 - AB194
[37] Real-time patient-reported outcomes in dermatology: proof of concept in patients treated with isotretinoin
Secrest, Aaron M.
Hopkins, Zachary H.
Frost, Zachary E.
Taliercio, Vanina L.
Biber, Joshua E.
Hess, Rachel
QUALITY OF LIFE RESEARCH, 2019, 28 : S159 - S160
[38] Disagreement between physician- and patient-reported disease severity in adults with a history of moderate-to-severe atopic dermatitis
Wei, W.
Anderson, P.
Gadkari, A.
Blackburn, S.
Moon, R.
Piercy, J.
Shinde, S.
Gomez, J.
Ghorayeb, E.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S23 - S23
[39] Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL)
Lacour, Jean-Philippe
Bewley, Anthony
Hammond, Edward
Hansen, Jes B.
Horne, Laura
Paul, Carle
Reich, Kristian
Seneschal, Julien
De Simone, Clara
Sohrt, Anne
Augustin, Matthias
Pellacani, Giovanni
DERMATOLOGY AND THERAPY, 2020, 10 (05) : 1099 - 1109
[40] Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL)
Jean-Philippe Lacour
Anthony Bewley
Edward Hammond
Jes B. Hansen
Laura Horne
Carle Paul
Kristian Reich
Julien Seneschal
Clara De Simone
Anne Sohrt
Matthias Augustin
Giovanni Pellacani
Dermatology and Therapy, 2020, 10 : 1099 - 1109

← 1 2 3 4 5 →